Sign In
Last checked at 
13 Sep 2012 07:00
Revolymer plc
("Revolymer" or "the Group")
Dr Bryan C Dobson to Join the Board of Revolymer
Former Croda International Plc ("Croda") executive to become an Independent Non-Executive Director
Revolymer (AIM: REVO), the British polymer company developing products for a number of high value fast moving consumer goods ("FMCG") markets, is pleased to announce with immediate effect the appointment of Dr Bryan Crawford Dobson to the Board of Directors as an independent non-executive director. Dr Dobson will also chair the Remuneration Committee.
Dr Dobson has 33 years' experience in the chemicals industry; 28 years with ICI and 5 years with Croda, and was most recently President Global Operations for Croda. He was a member of the executive management teams in Croda and in a number of large speciality chemicals businesses in ICI and has extensive management experience running regional and global business units in the UK, US, Belgium and The Netherlands. He also has expertise in developing new business in speciality chemicals sectors; extensive functional experience in R&D and operations and significant M&A experience.
Dr Dobson, commenting on his appointment said, "I am excited to be joining the Board of Revolymer and look forward to playing an active role in assisting the commercial and technical development of the Group, which has an attractive technology portfolio."
Jack Keenan, Chairman of Revolymer commenting on today's announcement said, "Bryan's decision to join the Board of Revolymer is yet another endorsement of the Group's technology and commercial strategy. His commercial and technical knowledge and expertise in both chemicals and FMCG markets complements well the skill base around the board table and will be instrumental in the further development of the Group's business."
Dr Dobson (aged 59) holds or has held the following directorships within the last 5 years:
Current | Previous |
The Newcastle upon Tyne Hospitals NHS Foundation Trust | Uniqema Nederland BV |
Durham Graphene Science Ltd |
|
Save as set out above, there is no information specified by paragraph (g) in Schedule Two to the AIM Rules that is required to be disclosed.
Ends
For further information please contact:
Revolymer plc | +44 (0) 1244 283 500 |
Roger Pettman Rob Cridland |
|
Panmure Gordon (UK) Limited | +44 (0) 20 7886 2500 |
Callum Stewart / Adam James (Corporate Finance) Adam Pollock / Charles Leigh-Pemberton (Corporate Broking) |
|
Citigate Dewe Rogerson | +44 (0)20 7638 9571 |
Simon Rigby / David Dible / Ginny Pulbrook |
|
About Revolymer
Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the confectionery chewing gum and medicated chewing gum (together "gum") markets; and in coatings & adhesives, household products and personal care (together "consumer specialties").
www.revolymer.com
Follow the stocks
